AstraZeneca opens new Massachusetts R&D center as part of $1 billion investment
AstraZeneca opens new Massachusetts R&D center as part of $1 billion investment Oct 5 (Reuters) - AstraZeneca AZN.L said on Monday it had opened a new research and development center in Cambridge, Massachusetts, as part of a more than $1 billion investment in the state to expand its research operations and workforce.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Maju Samuel)
Recent news on AstraZeneca
See all newsAstraZeneca fends off lawsuit over alleged Soliris drug monopoly (updated)
AstraZeneca fends off lawsuit over alleged Soliris drug monopoly
Sofinnova closes €725 million fund to back European biotech expansion
AstraZeneca gets US nod for expanded Imfinzi use, new rare-disease therapy
UK Stocks-Factors to watch on November 16 (updated)